From sustainability initiatives to ethical considerations and corporate governance, our report equips you with the knowledge to make informed decisions in the evolving ESG landscape of biopharma.

Morningstar’s ESG Commitment Level is represented on a four-point scale: Leader, Advanced, Basic, and Low. The ECL landscape assessment has been conducted on asset managers globally and aims to ...